EP Patent

EP2074127A1 — Pyrazolo [1, 5-a]pyrimidine derivatives and their therapeutic use

Assigned to Novartis AG · Expires 2009-07-01 · 17y expired

What this patent protects

Disclosed are pyrazolo-pyrimidine derivatives which have interesting pharmaceutical properties.

USPTO Abstract

Disclosed are pyrazolo-pyrimidine derivatives which have interesting pharmaceutical properties.

Drugs covered by this patent

Patent Metadata

Patent number
EP2074127A1
Jurisdiction
EP
Classification
—
Expires
2009-07-01
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.